Budesonide rectal foam for kids with mild-to-moderate ulcerative proctitis
Part of Digestive system clinical trials.
This trial tests different doses of budesonide rectal foam in children and teens (ages 5–17) with active, mild-to-moderate ulcerative colitis limited to the rectum and lowest part of the colon. It looks at safety, how well it works, and how the medicine moves through the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 5 to 17 years old (and not pregnant or breastfeeding).
- You have ulcerative colitis confirmed by symptoms plus colonoscopy/biopsy results.
- Your ulcerative colitis affects only the rectum and the last part of the colon (about 15 cm or less).
- Your disease is active but not severe: mild to moderate symptoms on a scoring system from endoscopy results.
- If you take oral 5-ASA (a type of UC medicine), your dose and form must have been unchanged for at least 6 weeks before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether budesonide extended-release tablets are safe and effective for improving symptoms in children ages 5–17 with active, mild to moderate ulcerative colitis. It also measures how the medicine moves through the body.
This trial studies whether combining a specific diet with an oral steroid called budesonide can calm symptoms in people with mild to moderate ulcerative colitis. It may help reduce inflammation in the colon while building on stable current treatments.
This trial tests whether butyrate can help children and teens with mild-to-moderate ulcerative colitis (a long-term bowel inflammation condition). You may be able to join if your symptoms fit the study level and you haven’t recently started other specific ulcerative colitis treatments right before the study begins.
This trial tests a specific probiotic (a type of beneficial bacteria) to see if it can help people with mild to moderate ulcerative colitis by improving the balance of gut microbes. It may be an option if you have not used many advanced treatments before.
This trial tests a new treatment for people with ulcerative colitis (UC) whose disease is active despite taking only mesalamine or sulfasalazine. It aims to find a therapy that can reduce inflammation and improve symptoms.
This trial studies whether transferring healthy stool bacteria into the gut (fecal microbiota transplantation, or FMT) can improve symptoms in children with ulcerative colitis. It may help by changing gut bacteria, especially for children who are newly diagnosed or who didn’t respond to standard treatments.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.